Trials / Completed
CompletedNCT00093873
Study Evaluating AMG 706 in Subjects With Advanced Solid Tumors
A Phase 1, First in Human, Open-Label, Dose Finding Study Evaluating the Safety and Pharmacokinetics of AMG 706 in Subjects With Advanced Solid Tumors
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 71 (actual)
- Sponsor
- Amgen · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study will determine the safety and pharmacokinetics of AMG 706 in subjects with advanced solid tumors.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Anti-angiogenesis | Anti-angiogenesis |
| DRUG | AMG 706 | Anti-angiogenesis |
Timeline
- Start date
- 2003-07-01
- Primary completion
- 2006-02-01
- Completion
- 2006-12-01
- First posted
- 2004-10-08
- Last updated
- 2013-05-15
Source: ClinicalTrials.gov record NCT00093873. Inclusion in this directory is not an endorsement.